Studies conducted on the B-cell receptor (BCR) have led to identifying two molecular subgroups: those harboring unmutated immunoglobulin heavy-chain variable region (IGHV) genes (U-CLL, ≥98% identity with the germline) and those with mutated IGHV genes (M-CLL). This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.